China-Biotics, Inc., a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, announced that the company had signed a one-year contract with Jiangxi Lijia Pharmaceutical Co., Ltd. (Lijia) to supply probiotics for Lijia's probiotics-based dietary supplements in both powder and tablet forms. The agreement runs through May 2009.

Lijia will use a combination of two Shining Probiotics, Bifidobacterium adolescentis and Bifidobacterium infantis, as additives in its newly developed dietary supplement powders and tablets. These probiotics will help to reduce the symptoms of lactose intolerance, to improve gastrointestinal tract health and to boost immune system health.

"We are delighted to begin providing our Shining Probiotics products to Lijia, a well-known, GMP-certified pharmaceutical company with many different products," said Jinan Song, China-Biotics' chairman and chief executive officer. "This is our first bulk additives customer specializing in the manufacturing of pharmaceuticals and supplements, an important part of our bulk additives growth strategy. We look forward to adding more bulk customers in new industries, which will further diversify our revenue stream. We are also excited to add new delivery forms of probiotics, which will further advance the public's health."

Based in Jiangxi Province, China, Lijia is engaged in the development, manufacturing and distribution of pharmaceuticals and supplements. It manufactures more than 60 products in its GMP-certified facility. Lijia's sales network spans more than 20 provinces in China.

Headquartered in Shanghai, China-Biotics, Inc. was founded in 1999 and is one of China's largest suppliers of probiotics. Probiotics are beneficial live bacteria used as dietary supplements and food additives to improve intestinal health and digestion. The Company's product portfolio contains live microbials made with proprietary technology.